Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_assertion type Assertion NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_head.
- NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_assertion description "[These results suggested that over-expression and activity of PKC? is closely associated with the regulation of the MDR phenotype in human colon cancer HCT15 cells and provided insight into a new strategy for inhibiting doxorubicin resistance in human cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.
- NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_assertion evidence source_evidence_literature NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.
- NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_assertion SIO_000772 22639047 NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.
- NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_assertion wasDerivedFrom befree-20150227 NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.
- NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_assertion wasGeneratedBy ECO_0000203 NP618753.RAwwiCxN2RoeG7W0RZB8HwYc9soCf9_FmjMucMXdTGhSg130_provenance.